These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 8259610)
1. [The PRP-D vaccination of Danish children. A study of immunogenicity of a Haemophilus influenzae type b vaccine coadministered with Di-Te-Pol to Danish children]. Konradsen HB; Ejlertsen T; Henrichsen J Ugeskr Laeger; 1993 Sep; 155(37):2872-5. PubMed ID: 8259610 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216 [TBL] [Abstract][Full Text] [Related]
3. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290 [TBL] [Abstract][Full Text] [Related]
5. [Vaccine against Haemophilus influenzae type b--antibody response and adverse effects]. Nøkleby H; Sandbu S; Käyhty H; Olander RM; Heilmann C Tidsskr Nor Laegeforen; 1995 May; 115(13):1604-6. PubMed ID: 7778073 [TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine. Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L; Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973 [TBL] [Abstract][Full Text] [Related]
10. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L; Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171 [TBL] [Abstract][Full Text] [Related]
12. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205 [TBL] [Abstract][Full Text] [Related]
13. [Seroconversion after vaccination against pertussis, Haemophilus influenzae type b and poliomyelitis in preterm infants]. Sikora JP; Chlebna-Sokół D Przegl Lek; 2003; 60(11):699-703. PubMed ID: 15058036 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants. Bavdekar SB; Maiya PP; Subba Rao SD; Datta SK; Bock HL Indian Pediatr; 2007 Jul; 44(7):505-10. PubMed ID: 17684303 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age. Pietrzyk JJ; Wysocki J; Pejcz J; Galaj A; Majda-Stanislawska E; Käyhty H; Thierry-Carstensen B; Jensen AM Vaccine; 2008 Sep; 26(41):5296-303. PubMed ID: 18675870 [TBL] [Abstract][Full Text] [Related]
17. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine. Nolan T; Altmann A; Skeljo M; Streeton C; Schuerman L Vaccine; 2004 Nov; 23(1):14-20. PubMed ID: 15519702 [TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age. Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057 [TBL] [Abstract][Full Text] [Related]
19. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781 [TBL] [Abstract][Full Text] [Related]
20. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine. Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]